As of 2:30 PM on the 14th, Bukwang Pharm is trading at 26,350 KRW, up 0.38% from the previous day. This marks an 18.43% increase compared to April 13. Bukwang Pharm is known as a manufacturer of pharmaceuticals and quasi-drugs (such as toothpaste).
Today, foreigners have net sold 14,000 shares of Bukwang Pharm, while institutions have net bought 4,000 shares, according to provisional data. Over the past five days, individual investors have net bought 361,517 shares, while foreigners and institutions have net sold 351,546 shares and net bought 48,655 shares, respectively.
On May 12, Bukwang Pharm was a market topic with the headline "Rapid surge... faster development of COVID-19 treatment than Celltrion."

[Table] Net Trading Volume of Foreigners and Institutions (Unit: shares)

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

